Feature Channels:

Clinical Trials

Add to Favorites Subscribe Share
fbshare-Clinical Trials

Showing results

110 of 120
HMH-Logo.jpg

Article ID: 719305

Hackensack University Medical Center Announces Participation in Investigational, One-Time Gene Therapy Clinical Trial for Parkinson’s Patients

Hackensack Meridian Health

The Division of Movement Disorders at Hackensack University Medical Center has been selected to participate in the RESTORE-1 Phase 2 Clinical Study of VY-AADC, an investigational gene therapy for Parkinson’s disease.

Released:
19-Sep-2019 3:05 PM EDT
Embargo will expire:
24-Sep-2019 12:00 AM EDT
Released to reporters:
17-Sep-2019 2:05 PM EDT

EMBARGOED

A reporter's PressPass is required to access this story until the embargo expires on 24-Sep-2019 12:00 AM EDT

The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application.
If you have not yet registered, please do so. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Horizontal-CHLA-Logo.png

Article ID: 719042

First Positive Results in 45 Years: Rhabdomyosarcoma Randomized Clinical Trial Led by Children’s Hospital Los Angeles

Children's Hospital Los Angeles

A randomized clinical trial led at Children's Hospital Los Angeles by Leo Mascarenhas, MD, MS, showed first positive results in rhabdomyosarcoma since 1974.

Released:
17-Sep-2019 8:00 AM EDT
PennMed_logo.png

Article ID: 719002

Penn’s Angela DeMichele, MD, MSCE, Part of Team Awarded Stand Up 2 Cancer Grant

Perelman School of Medicine at the University of Pennsylvania

A new $3 million grant to support a clinical trial evaluating a combination therapy to prevent triple-negative breast cancer from recurring, which will be led in the clinic by Angela DeMichele, MD, MSCE, the Alan and Jill Miller Professor in Breast Cancer Excellence in the Abramson Cancer Center (ACC) at the University of Pennsylvania and co-director of the ACC’s 2-PREVENT Translational Center of Excellence. The grant was awarded by Stand Up 2 Cancer (SU2C) in partnership with Genentech, and will be administered by the organization’s scientific partner, the American Association for Cancer Research (AACR).

Released:
16-Sep-2019 10:00 AM EDT
Childrens of Alabama_stacked_registered.jpg

Article ID: 718731

Cancer Predisposition Clinic Aims To Change Trajectory Of Genetically Based Cancer

Children's of Alabama

Children’s of Alabama’s Cancer Predisposition Clinic physicians develop personalized screening for children who have inherited cancer predisposition syndromes with hopes that early detection will lead to improved outcomes.

Released:
12-Sep-2019 5:00 AM EDT
Newswise: FDA Phase 1 Trial Shows Hydrogel to Repair Heart Is Safe to Inject in Humans—a First
  • Embargo expired:
    11-Sep-2019 2:00 PM EDT

Article ID: 718618

FDA Phase 1 Trial Shows Hydrogel to Repair Heart Is Safe to Inject in Humans—a First

University of California San Diego

Ventrix, a University of California San Diego spin-off company, has successfully conducted a first-in-human, FDA-approved Phase 1 clinical trial of an injectable hydrogel that aims to repair damage and restore cardiac function in heart failure patients who previously suffered a heart attack.

Released:
9-Sep-2019 8:00 AM EDT
Newswise: Two commonly used uveitis drugs perform similarly in NIH-funded clinical trial
  • Embargo expired:
    10-Sep-2019 11:00 AM EDT

Article ID: 718592

Two commonly used uveitis drugs perform similarly in NIH-funded clinical trial

NIH, National Eye Institute (NEI)

Methotrexate and the more expensive mycophenolate mofetil performed similarly in a head-to-head clinical trial that compared the two drugs for treating noninfectious uveitis

Released:
6-Sep-2019 2:00 PM EDT

Article ID: 718715

Ablacon Announces Release of New and Improved Ablamap Technology Under Existing CE Mark

Ablacon, Inc.

Ablacon, Inc. (www.ablacon.com), an Ajax Health-funded company, announced today the release of an updated version of its Ablamap technology under the company's existing CE Mark.

Released:
10-Sep-2019 8:05 AM EDT
Newswise: KU Cancer Center receives grant to expand clinical trials in rural Kansas

Article ID: 718706

KU Cancer Center receives grant to expand clinical trials in rural Kansas

University of Kansas Cancer Center

The University of Kansas Cancer Center and Midwest Cancer Alliance have been awarded a grant to expand the reach of cancer clinical trials to Kansas’ rural communities.

Released:
9-Sep-2019 6:05 PM EDT

Showing results

110 of 120

Chat now!